Skip to main content

MODERN Labeling Act Needs Liability Protection for Generics

This piece looks at what could make the proposed Making Objective Drug Evidence Revisions for New Modern Labeling (MODERN) Act stronger - primarily liability protection for generics. Joanne Hawana is among the FDA industry sources quoted providing commentary in the piece.


Inside Health Policy